70 related articles for article (PubMed ID: 6228469)
21. Hepatitis B vaccine: safety study in anti-HBs seropositive human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():223-7. PubMed ID: 6228462
[TBL] [Abstract][Full Text] [Related]
22. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
[TBL] [Abstract][Full Text] [Related]
23. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
24. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
25. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
26. [Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children--a 12-year follow-up].
Liao S; Li R; Li H; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):89-94. PubMed ID: 11367725
[TBL] [Abstract][Full Text] [Related]
27. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
Li H; Li R; Liao S; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
[TBL] [Abstract][Full Text] [Related]
28. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
[TBL] [Abstract][Full Text] [Related]
29. The use of hepatitis B vaccine as booster for donors immune to HBV for the production of hepatitis B immunoglobulin (HBIG).
Couroucé AM; Bouchardeau F; Le Marrec N; Boulard G; Soulier JP
Dev Biol Stand; 1983; 54():333-40. PubMed ID: 6228472
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
31. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
32. [Hepatitis B vaccination - before a breakthrough?].
Grob PJ
Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1146-53. PubMed ID: 7025194
[TBL] [Abstract][Full Text] [Related]
33. Five-year follow-up of immune response to hepatitis B vaccine in juveniles.
Zhang MT; Liu KZ; Jin JH; Ding LM; Zhou SC; Yu QY; Zhang XZ
Chin Med J (Engl); 1993 Feb; 106(2):97-9. PubMed ID: 8504700
[TBL] [Abstract][Full Text] [Related]
34. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
[TBL] [Abstract][Full Text] [Related]
35. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
36. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
[TBL] [Abstract][Full Text] [Related]
37. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial.
Desmyter J; Colaert J; De Groote G; Reynders M; Reerink-Brongers EE; Lelie PN; Dees PJ; Reesink HW
Lancet; 1983 Dec; 2(8363):1323-8. PubMed ID: 6139668
[TBL] [Abstract][Full Text] [Related]
40. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
